The Patent Finder

Terms ending in 2037

Actelion Pharmaceuticals Ltd

Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,011,444N-Substituted Indole Derivatives as PGE2 Receptor Modulators
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 10,653,846Dosing Appratus for Dispensing a Fluid Under Aseptic Conditions
In force
 · High confidence
SHL Medical AGIn forceHigh confidence
US 10,752,620Piperdine CXCR7 Receptor Modulators
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 10,730,896Crystalline Forms
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 11,365,209Crystalline Forms
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 12,227,532Crystalline Forms
In force
 · High confidence
Viatris Asia Pacific Pte. Ltd.In forceHigh confidence
US 11,185,629Dosing Apparatus and Injection Device
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 11,174,247Combinations of a 4-Pyrimidinesulfamide Derivative with Active Ingredients for the Treatment of Endothelin Related Diseases
In force
 · High confidence
Idorsia Pharmaceuticals Ltd.In forceHigh confidence
US 10,087,171Crystalline Forms of Cadazolid
In force
 · High confidence
Actelion Pharmaceuticals Ltd.In forceHigh confidence
9 of 9 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited